Optimizing perinatal wellbeing in pregnancy with obesity: a clinical trial with a multi-component nutrition intervention for prevention of gestational diabetes and infant growth and neurodevelopment impairment.

Autor:	Perichart-Perera O; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Reyes-Muñoz E; Gynecological and Perinatal Endocrinology Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Borboa-Olivares H; Community Interventions Research Branch, Instituto Nacional de Perinatología, Mexico City, Mexico., Rodríguez-Cano AM; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Solis Paredes JM; Department of Research in Reproductive and Perinatal Health, Instituto Nacional de Perinatología, Mexico City, Mexico., Hernández-Hernández L; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Rodríguez-Hernández C; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., González-Ludlow I; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Suárez-Rico BV; Research Division, Instituto Nacional de Perinatología, Mexico City, Mexico., Sánchez-Martínez M; Department of Immunobiochemistry, Instituto Nacional de Perinatología, Mexico City, Mexico., Torres-Herrera U; Department of Obstetrics, Instituto Nacional de Perinatología, Mexico City, Mexico., Canul-Euan AA; Department of Neurodevelopmental Biology, Instituto Nacional de Perinatología, Mexico City, Mexico., Tolentino-Dolores M; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatología, Mexico City, Mexico., Espejel-Nuñez A; Department of Immunobiochemistry, Instituto Nacional de Perinatología, Mexico City, Mexico., Estrada-Gutierrez G; Research Division, Instituto Nacional de Perinatología, Mexico City, Mexico.
Jazyk:	angličtina
Zdroj:	Frontiers in medicine [Front Med (Lausanne)] 2024 Apr 12; Vol. 11, pp. 1339428. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).
DOI:	10.3389/fmed.2024.1339428
Abstrakt:	Pregnancy complicated by obesity represents an increased risk of unfavorable perinatal outcomes such as gestational diabetes mellitus (GDM), hypertensive disorders in pregnancy, preterm birth, and impaired fetal growth, among others. Obesity is associated with deficiencies of micronutrients, and pregnant women with obesity may have higher needs. The intrauterine environment in pregnancies complicated with obesity is characterized by inflammation and oxidative stress, where maternal nutrition and metabolic status have significant influence and are critical in maternal health and in fetal programming of health in the offspring later in life. Comprehensive lifestyle interventions, including intensive nutrition care, are associated with a lower risk of adverse perinatal outcomes. Routine supplementation during pregnancy includes folic acid and iron; other nutrient supplementation is recommended for high-risk women or women in low-middle income countries. This study is an open label randomized clinical trial of parallel groups (UMIN Clinical Trials Registry: UMIN000052753, https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060194) to evaluate the effect of an intensive nutrition therapy and nutrient supplementation intervention (folic acid, iron, vitamin D, omega 3 fatty acids, myo-inositol and micronutrients) in pregnant women with obesity on the prevention of GDM, other perinatal outcomes, maternal and newborn nutritional status, and infant growth, adiposity, and neurodevelopment compared to usual care. Given the absence of established nutritional guidelines for managing obesity during pregnancy, there is a pressing need to develop and implement new nutritional programs to enhance perinatal outcomes. Competing Interests: OP-P, ER-M, and AR-C are speakers of Nestle Nutrition Institute. OP-P and ER-M are speakers of Exeltis Pharma Mexico. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Perichart-Perera, Reyes-Muñoz, Borboa-Olivares, Rodríguez-Cano, Solis Paredes, Hernández-Hernández, Rodríguez-Hernández, González-Ludlow, Suárez-Rico, Sánchez-Martínez, Torres-Herrera, Canul-Euan, Tolentino-Dolores, Espejel-Nuñez and Estrada-Gutierrez.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu